Assessment of antibiotic prescriptions in pediatric care units in a regional university hospital

Infect Dis Now. 2021 Feb;51(1):55-60. doi: 10.1016/j.medmal.2020.04.017. Epub 2020 Apr 29.

Abstract

Objectives: The main objective was to assess the relevance of antibiotic prescriptions in the pediatric wards of a regional university hospital in France. Secondary objectives were to assess adequacy of the dose, administration frequency, administration route, treatment duration, adaptation to bacteriological results, and treatment reevaluation.

Patients and methods: We assessed antibiotic prescriptions in pediatric settings. We included all patients under 18 years of age hospitalized in a pediatric ward who received a computerized prescription for antibiotic treatment between June 1st and June 30th, 2018; 163 clinical cases for 157 patients were analyzed. Patients hospitalized in neonatology, pediatric intensive care unit, and onco-hematology wards were excluded.

Results: The rate of relevance was 71%. The rates of adequacy for the other criteria were 60% for the dose, 99% for the administration frequency, 98% for the administration route, 72% for treatment duration, 98% for treatment adaptation to microbiological results, and 100% for treatment revaluation. All criteria combined, the overall rate of adequacy was 28%.

Conclusions: Effort should be made regarding doses and treatment durations. Areas for improvement have been suggested to the wards: standardized prescription protocols, pediatric prescription guide, training of residents, setting up of the operational team in pediatric wards and a second clinical evaluation.

Keywords: Antibiotic stewardship; Assessment of professional practices; Pediatrics.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / administration & dosage*
  • Antimicrobial Stewardship / methods
  • Child
  • Child, Preschool
  • Drug Administration Routes
  • Drug Prescriptions / statistics & numerical data*
  • Duration of Therapy
  • Female
  • France
  • Hospitals, University*
  • Humans
  • Infant
  • Infant, Newborn
  • Infections / drug therapy*
  • Male
  • Pediatrics
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents